Get the Stockscreener App
2.09
0.97%
0.02
Pre-market:
2.10
0.01
+0.48%
Inovio Pharmaceuticals Inc stock is traded at $2.09, with a volume of 1.20M.
It is up +0.97% in the last 24 hours and down -1.42% over the past month.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
See More
Previous Close:
$2.07
Open:
$2.08
24h Volume:
1.20M
Relative Volume:
1.01
Market Cap:
$143.59M
Revenue:
$832.00K
Net Income/Loss:
$-135.12M
P/E Ratio:
-0.3432
EPS:
-6.09
Net Cash Flow:
$-124.69M
1W Performance:
+8.85%
1M Performance:
-1.42%
6M Performance:
-7.93%
1Y Performance:
-49.88%
1-Day Range:
$2.065
$2.17
1-Week Range:
$1.86
$2.17
52-Week Range:
$1.30
$4.4383
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Name
Inovio Pharmaceuticals Inc
Sector
Industry
Phone
(858) 410-3134
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.09 | 142.22M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.04 | 115.56B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
703.26 | 75.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.02 | 60.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
900.76 | 55.48B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
196.55 | 43.51B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Jan-25-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-09-22 | Downgrade | Maxim Group | Buy → Hold |
| Nov-01-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-19-22 | Resumed | RBC Capital Mkts | Sector Perform |
| May-11-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-29-21 | Resumed | Jefferies | Hold |
| Sep-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-24-21 | Initiated | Jefferies | Hold |
| Mar-23-21 | Initiated | BofA Securities | Neutral |
| Feb-12-21 | Initiated | Oppenheimer | Outperform |
| Nov-17-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Nov-10-20 | Upgrade | ROTH Capital | Sell → Neutral |
| Sep-28-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-28-20 | Upgrade | Maxim Group | Hold → Buy |
| Jul-01-20 | Downgrade | Maxim Group | Buy → Hold |
| Jul-01-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Jun-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-20 | Downgrade | Stifel | Buy → Hold |
| May-21-20 | Initiated | The Benchmark Company | Buy |
| Apr-30-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Mar-13-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-13-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-19-19 | Initiated | ROTH Capital | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
| Oct-18-17 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-17 | Initiated | Citigroup | Buy |
| Jun-08-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-24-17 | Reiterated | Maxim Group | Buy |
| Mar-16-17 | Upgrade | Maxim Group | Hold → Buy |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
View All
Inovio Pharmaceuticals Inc Stock (INO) Latest News
Will Inovio Pharmaceuticals Inc. stock see insider buying2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
How Inovio Pharmaceuticals Inc. stock performs in weak economyWeekly Trade Analysis & Fast Gaining Stock Reports - Newser
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsJuly 2025 Rallies & Stock Timing and Entry Methods - Newser
Inovio Pharmaceuticals Inc. Stock Advances 5.2%, Outperforms Market - 富途牛牛
Will Inovio Pharmaceuticals Inc. (GBM) stock beat value stocksEarnings Performance Report & Weekly Stock Performance Updates - Newser
Is Inovio Pharmaceuticals Inc. (GBM) stock good for wealth creationTrade Risk Report & Free Long-Term Investment Growth Plans - Newser
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthMarket Movement Recap & Stepwise Trade Signal Implementation - Newser
Is Inovio Pharmaceuticals Inc. (GBM) stock expanding market penetrationDollar Strength & High Conviction Investment Ideas - Newser
INO: INO-3107 shows strong efficacy and safety in RRP, with launch preparations underway for 2025 - TradingView
Trend Recap: Will Inovio Pharmaceuticals Inc stock see insider buying2025 Volatility Report & Low Risk High Win Rate Picks - BỘ NỘI VỤ
Is Inovio Pharmaceuticals Inc. (GBM) stock a fit for income portfoliosJuly 2025 Trends & AI Based Buy/Sell Signal Reports - Newser
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
What Valuation Gaps Could Correct in Kronox Lab Sciences Limited Stock PriceVolatility Adjusted Trading & Small Budget Wealth Tips - earlytimes.in
Is Inovio Pharmaceuticals Inc. (GBM) stock a top dividend aristocrat candidateJuly 2025 Movers & Weekly Momentum Stock Picks - BỘ NỘI VỤ
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults (PR Newswire) - Aktiellt
INOVIO Maps Out High-Stakes December as Investors Eye Rare Disease Catalysts - MyChesCo
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering - MSN
What analysts say about Inovio Pharmaceuticals Inc GBM stockStock Buyback Updates & High Return Portfolio Growth - earlytimes.in
How strong is Inovio Pharmaceuticals Inc. (GBM) stock earnings growth2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
What sentiment indicators say about Inovio Pharmaceuticals Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock gain from lower interest ratesWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
INOVIO Advances Toward First Commercial Product as BLA Filing Caps Pivotal Quarter - MyChesCo
Why Inovio Pharmaceuticals Inc. stock is favored by top institutions2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Is Inovio Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Why analysts maintain buy rating on Inovio Pharmaceuticals Inc. (GBM) stockMarket Growth Review & Weekly Return Optimization Alerts - newser.com
HC Wainwright Issues Optimistic Forecast for INO Earnings - MarketBeat
Published on: 2025-11-20 00:40:52 - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock survive global slowdownTrend Reversal & Low Volatility Stock Recommendations - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock attract long term capital inflows2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock inflation resilientEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe chartsDollar Strength & AI Enhanced Execution Alerts - newser.com
What is the fair value estimate for Inovio Pharmaceuticals Inc. (GBM) stock in 2025 - newser.com
Why Inovio Pharmaceuticals Inc. stock is rated strong buy2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Inovio Pharmaceuticals Inc Stock (INO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):